Hepatic Vein Pressure Gradient
Showing 1 - 25 of >10,000
Portal Hypertension, Non-Cirrhotic Portal Hypertension, Non-Cirrhotic Portal Fibrosis Trial in Rio de Janeiro (Hepatic vein
Not yet recruiting
- Portal Hypertension
- +9 more
- Hepatic vein pressure gradient measurement
- +2 more
-
Rio de Janeiro, RJ, BrazilHospital Universitário Clementino Fraga Filho / Universidade Fed
Jan 30, 2023
Cirrhosis, Portal Hypertension Trial in Alicante (EUS-PPG and HVPG)
Recruiting
- Cirrhosis
- Portal Hypertension
- EUS-PPG and HVPG
-
Alicante, SpainUnidad de Endoscopia. Hospital General Universitario de Alicante
Jan 17, 2023
Predicting the Prognosis of HCC With TACE (CHANCE-CHESS 2302)
Not yet recruiting
- Hepatocellular Carcinoma
- Portal Hypertension
- TACE ± Systemic therapy
-
Nanjing, China
- +1 more
Jan 28, 2023
The Precise Selection of Stent Diameter for Portal Hypertension
Recruiting
- Compensated Advanced Chronic Liver Disease
- Portal Hypertension
- a non-invasive technology to evaluate hepatic venous pressure gradient and portal pressure gradient
-
Hangzhou, ChinaFirst Affiliated Hospital of Zhejiang University
Mar 17, 2022
HVPG and ICG-R15 in Short- and Medium-term Results of Surgery of
Recruiting
- Hepatocellular Carcinoma
- Hepatic venous-portal gradient (HVPG) measurement
-
Napoli, ItalyFederico II University Hospital
Mar 24, 2023
Portal Hypertension, Chronic Liver Disease, Cirrhosis Trial in Montréal (Transjugular hepatic venous pressure gradient
Recruiting
- Portal Hypertension
- +2 more
- Transjugular hepatic venous pressure gradient measurement with liver biopsy
- Endoscopic ultrasound portal pressure gradient measurement with liver biopsy
-
Montréal, Quebec, CanadaMcGill University Health Centre
Dec 5, 2021
Liver Disease Trial in Aurora (HepQuant-SHUNT (Drug and Device) #65,123 (4D-cholate) and IND #65,121 (13C-cholate), Hepatic
Completed
- Liver Disease
- HepQuant-SHUNT (Drug and Device) #65,123 (4D-cholate) and IND #65,121 (13C-cholate)
- Hepatic Venous Pressure Gradient (HVPG)
-
Aurora, ColoradoUniversity of Colorado Denver (Leprino Building)
Aug 5, 2021
Liver Cirrhoses, Variceal Hemorrhage, Esophageal Varices Trial in Xi'an (Transjugular intrahepatic portosystemic shunt,
Not yet recruiting
- Liver Cirrhoses
- +2 more
- Transjugular intrahepatic portosystemic shunt
- +2 more
-
Xi'an, Shaanxi, ChinaFourth Military Medical University
Feb 2, 2020
Pre-operative EUS Guided and Intra-operative Direct Portal Vein
Not yet recruiting
- Liver Cirrhosis
- EUS Portal pressure measurement
- (no location specified)
Nov 1, 2023
Based on Spleen Stiffness, Liver Stiffness and Platelets for
Recruiting
- Portal Hypertension
- Hepatic venous pressure gradient
-
Lanzhou, Gansu, China
- +4 more
May 27, 2022
Liver Diseases, Liver Transplantation Trial (Partial hepatectomy (open approach), liver transplantation, Portal vein
Recruiting
- Liver Diseases
- Liver Transplantation
- Partial hepatectomy (open approach)
- +2 more
-
Villejuif, Val De Marne, FranceCentre Hépato-Biliaire - Hôpital Paul Brousse
Jan 16, 2023
Based on Smartphone-derived Multimodality Images to Evaluate
Recruiting
- Portal Hypertension
- Hepatic venous pressure gradient
-
Beijing, Beijing, China
- +1 more
May 30, 2022
PVP on Clinical Outcomes in Patients With PH
Recruiting
- Portal Hypertension
- monitoring portal pressure gradient or hepatic venous pressure gradient
-
Guangzhou, Guangdong, ChinaNanfang Hospital
Mar 26, 2021
A Novel Algorithm to Stratify Decompensation Risk in Compensated
Not yet recruiting
- Compensated Advanced Chronic Liver Disease
- Esophagogasrtoduodendoscopy
- Hepatic venous pressure gradient
- (no location specified)
Oct 20, 2021
A Novel Spleen-dedicated Stiffness Measured by FibroScan to
Not yet recruiting
- Portal Hypertension
- Hepatic venous pressure gradient
-
Hangzhou, China
- +2 more
Sep 12, 2021
Portal Hypertension Trial in New Delhi (Carvedilol)
Not yet recruiting
- Portal Hypertension
-
New Delhi, Delhi, IndiaInstitute of Liver & Biliary Sciences
Mar 1, 2023
Portal Hypertension, Cirrhosis Trial in Hong Kong (EUS-portal pressure gradient measurement (PPGM))
Recruiting
- Portal Hypertension
- Cirrhosis
- EUS-portal pressure gradient measurement (PPGM)
-
Hong Kong, Hong Kong, ChinaChinese University of Hong Kong
Nov 27, 2021
A Practical Nomogram Based on Systemic Inflammatory Markers for
Completed
- Systemic Inflammatory Markers
- Portal Vein Thrombosis
- clinical laboratory tests, and imaging characteristics
-
Qingdao, Shandong, Chinathe Affiliated Hospital of Qingdao University
Sep 13, 2022
Portal Hypertension Trial in Nanjing (Endoscopy+NSBBs, Transjugular intrahepatic portosystemic shunt)
Recruiting
- Portal Hypertension
- Endoscopy+NSBBs
- Transjugular intrahepatic portosystemic shunt
-
Nanjing, Jiangsu, ChinaNanjing Drum Tower Hospital
Aug 22, 2023
CHESS-SAVE Score to Stratify Decompensation Risk in Compensated
Not yet recruiting
- Compensated Advanced Chronic Liver Disease
- Esophagogasrtoduodendoscopy and liver stiffness
- hepatic venous pressure gradient
-
Shanghai, China
- +6 more
Jul 14, 2021
Hypertension, Portal, Liver Cirrhosis Trial (Placebo, BI 685509)
Not yet recruiting
- Hypertension, Portal
- Liver Cirrhosis
- Placebo
- BI 685509
- (no location specified)
Oct 9, 2023
Liver Cirrhosis, Portal Hypertension, Pain Trial in Lanzhou (Fentanyl)
Unknown status
- Liver Cirrhosis
- +2 more
-
Lanzhou, Gansu, ChinaThe First Hospital of Lanzhou University
Jan 25, 2021
Cirrhosis Portal Trial (EUS guided portal pressure gradient measurement)
Not yet recruiting
- Cirrhosis Portal
- EUS guided portal pressure gradient measurement
- (no location specified)
Oct 24, 2022
(CHESS1904): An International Multicenter Survey
Recruiting
- Portal Hypertension
- Cirrhosis, Liver
- Questionnaire
-
Recife, Brazil
- +9 more
Feb 22, 2021
Liver Diseases, Portal Hypertension Trial in Philadelphia, Bern (SHAPE measurement (Sonazoid ultrasoud contrast agent), SHAPE
Not yet recruiting
- Liver Diseases
- Portal Hypertension
- SHAPE measurement (Sonazoid ultrasoud contrast agent)
- SHAPE measurement (Definity ultrasoud contrast agent)
-
Philadelphia, Pennsylvania
- +2 more
Jul 20, 2022